Tang, Yong, and Yibin Kang. (2022) 2022. “Microbial Metabolite As Icebreaker for Immunotherapy”. Cell Metab 34 (4): 506-7. doi:10.1016/j.cmet.2022.03.003.

Pérez-Núñez, Iván, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, et al. (2022) 2022. “LCOR Mediates Interferon-Independent Tumor Immunogenicity and Responsiveness to Immune-Checkpoint Blockade in Triple-Negative Breast Cancer”. Nat Cancer 3 (3): 355-70. doi:10.1038/s43018-022-00339-4.

Esposito, Mark, Shridar Ganesan, and Yibin Kang. (2021) 2021. “Emerging Strategies for Treating Metastasis”. Nat Cancer 2 (3): 258-70. doi:10.1038/s43018-021-00181-0.

Aiello-Couzo, Nicole, and Yibin Kang. (2020) 2020. “A Bridge Between Melanoma Cell States”. Nat Cell Biol 22 (8): 913-14. doi:10.1038/s41556-020-0556-2.

Li, Zhuo, and Yibin Kang. (2016) 2016. “Emerging Therapeutic Targets in Metastatic Progression: A Focus on Breast Cancer.”. Pharmacol Ther 161: 79-96. doi:10.1016/j.pharmthera.2016.03.003.